Okay, let's tackle this question about the cofactor for lipoprotein lipase. First, I need to recall what lipoprotein lipase (LPL) does. LPL is an enzyme that breaks down triglycerides in lipoproteins like chylomicrons and VLDL into free fatty acids and glycerol. This process is crucial for delivering energy to tissues.

Now, cofactors for enzymes are substances that help the enzyme function. For LPL, I remember that it requires a protein to be active. Apolipoproteins come to mind. Specifically, apo C-II is known as an activator of LPL. Apo C-II is part of the chylomicrons and VLDL, and when it binds to LPL, it enhances the enzyme's activity. So the cofactor here should be apo C-II.

Looking at the options provided, the correct answer would be the option that lists apo C-II. The other options might include other apolipoproteins like apo B, apo A-I, or apo E. Let's check each one. Apo B is involved in receptor recognition, not LPL activation. Apo A-I is part of HDL and involved in reverse cholesterol transport. Apo E is involved in receptor-mediated uptake by the liver. So those are not cofactors for LPL.

Clinical pearl: Remember that apo C-II is the cofactor for LPL, and deficiency in apo C-II can lead to chylomicronemia syndrome, where triglycerides accumulate because LPL can't function properly. This is a high-yield point for exams because it ties the cofactor to a specific disease, which helps in retention.

**Core Concept** Lipoprotein lipase (LPL) hydrolyzes triglycerides in chylomicrons and VLDL. Its activity depends on a cofactor, **apolipoprotein C-II (apo C-II)**, which binds to and activates the enzyme, enabling lipid metabolism in adipose and muscle tissues.

**Why the Correct Answer is Right** Apolipoprotein C-II (apo C-II) is the essential cofactor for LPL. It binds to LPL's active site, stabilizing the enzyme-lipoprotein complex and facilitating triglyceride hydrolysis. Without apo C-II, LPL remains inactive, leading to chylomicron accumulation (e.g., in apo C-II deficiency or familial lipoprotein lipase deficiency).

**Why Each Wrong Option is Incorrect**
**Option A:** *Apolipoprotein B (apo B)* is a structural component of lipoproteins but does not activate LPL.
**Option B:** *Apolipoprotein A-I (apo A-I)* is critical for HDL formation and reverse cholesterol transport, unrelated to LPL activation.
**Option C:** *Apolipoprotein E (apo E)* mediates lipoprotein uptake via LDL receptors, not LPL activity.

**Clinical Pearl / High-Yield Fact** Remember: **"C-II = LPL’s cofactor; no C-II, no LPL action."** Deficiency in apo C-II or LPL causes **familial chylomicronemia syndrome**, marked by severe hypertriglyceridemia and eruptive xanthomas.

**Correct Answer: C. Apolipoprotein C-II**

✓ Correct Answer: C. apo C-II